99558-25-5

Upstream product

• 22446-37-3 methyl (2-hydroxyphenyl)acetate 
• 153623-44-0 (2-allyloxyphenyl)acetic acid methyl ester 
• 106-95-6 allyl bromide 
• 614-75-5 2-Hydroxyphenylacetic acid 

Downstream Products

• 99558-26-6 4-(2-allyloxyphenyl)-4,5-dihydropyridazin-3(2H)-one 
• 383422-23-9 (2-Allyloxy-phenyl)-acetic acid (2S,3R,4S,5R,6R)-4,5-bis-benzyloxy-6-benzyloxymethyl-2-ethylsulfanyl-tetrahydro-pyran-3-yl ester 
• 383422-22-8 (2-Allyloxy-phenyl)-acetic acid (2S,4aR,6S,7R,8S,8aS)-8-benzyloxy-6-ethylsulfanyl-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-7-yl ester 
• 383422-33-1 (2-Allyloxy-phenyl)-acetic acid (2S,4aR,6R,7R,8S,8aS)-6-((2R,3R,4S,5R,6S)-4-acetoxy-5-benzyloxy-3-hydroxy-6-methoxy-tetrahydro-pyran-2-ylmethoxy)-8-benzyloxy-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-7-yl ester 
• 383422-28-4 (2-Allyloxy-phenyl)-acetic acid (2S,4aR,6R,7R,8S,8aS)-6-((2R,3R,4S,5R,6S)-4-acetoxy-3,5-bis-benzyloxy-6-methoxy-tetrahydro-pyran-2-ylmethoxy)-8-benzyloxy-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-7-yl ester 
• 383422-31-9 4-Oxo-pentanoic acid (2R,3R,4S,5R,6S)-4-acetoxy-2-{(2S,4aR,6R,7R,8S,8aS)-7-[2-(2-allyloxy-phenyl)-acetoxy]-8-benzyloxy-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-6-yloxymethyl}-5-benzyloxy-6-methoxy-tetrahydro-pyran-3-yl ester 
• 383422-35-3 Benzoic acid (2R,4aR,6S,7R,8S,8aR)-8-{(2S,3R,4S,5R,6R)-3-[2-(2-allyloxy-phenyl)-acetoxy]-4,5-bis-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-2-yloxy}-6-methoxy-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-7-yl ester 
• 383422-26-2 Benzoic acid (2R,3R,4S,5R,6S)-2-{(2S,4aR,6R,7R,8S,8aS)-7-[2-(2-allyloxy-phenyl)-acetoxy]-8-benzyloxy-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-6-yloxymethyl}-3,5-bis-benzyloxy-6-methoxy-tetrahydro-pyran-4-yl ester 

Relevant academic research and scientific papers

6-exo-trig Michael addition-lactonizations for catalytic enantioselective chromenone synthesis

The catalytic enantioselective 6-exo-trig Michael addition-lactonization of enone-acid substrates to form cis-chromenones with high diastereo- and enantiocontrol was developed using the commercially available isothiourea tetramisole. An acidic workup prov

Pyrazolopyrimidine Macrocycles as Inhibitors of Human Immunodeficiency Virus Replication

The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compound

The 2-(allyloxy) phenyl acetyl ester as a new relay protecting group for oligosaccharide synthesis

The 2-(allyloxy) phenyl acetyl group can be removed by a relay approach using Pd(PPh3)4 in combination with proton sponge, conditions that do not affect acetyl, benzoyl and levulinoyl esters. On the other hand, the acetyl and levulin

PREPARATION AND SOME REACTIONS OF 4- AND 5-ARYL-4,5-DIHYDROPYRIDAZIN-3(2H)-ONES

Efficient preparations of 4- and 5-phenyl-4,5-dihydropyridazin-3(2H)-ones have been developed, the main reactions of these compounds have been studied, and the synthetic routes have been used to give analogues with substituents in the phenyl rings.In the best synthesis of the 4-phenyldihyropyridazinone (72 percent overall yield) the product was obtained from phenylacetic acid by three simple stages.This approach was applied in preparations of the 2- and 4-hydroxyphenyl compounds and, in conjunction with a recent method for amine protection, the 4-aminophenyl analogue.A four stage synthesis starting from benzaldehyde gave the 5-phenyldihydropyridazinone in 47 percent overall yield; hydroxybenzaldehydes were similarly converted into 5-(allyloxyphenyl)dihydropyridazinones.Oxidation to phenylpyridazinones occured more readily with the 4- and 5-phenyldihydropyridazinones than with the 6-phenyl isomer.The 4- and 5-dihydropyridazinones were smoothly reduced to tetrahydropyridazinones by hydrogenation over platinum but were uneffected by palladium in the presence of hydrazine or cyclohexene.